Palantir Just Beat Earnings, Yet Stock Dives Again
Palantir just beat earnings, yet its stock fell in after-hours trading as traders priced in slower growth and macro h...
User Friendly Finance Management Tools
Simplify your finances with user-friendly finance management tools. These resources will help you stay organized and in control of your money.
22,433 articles
Where Will Berkshire Hathaway Stock Go Over the Next 5 Years
Berkshire Hathaway stands at a pivotal crossroads as a new era begins. This article breaks down five-year scenarios, ...
Worksport (WKSP) 2026 Earnings: Q1 Insights and Outlook
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...
B&G Foods: Foods (BGS) 2026 Earnings Outlook and Guide
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
Alumis Stock Soared 400%: Cormorant Buys Another $8M
A sharp rise in Alumis shares coincides with a fresh stake from Cormorant Asset Management. This article breaks down ...
Credo Stock Opens Door for Bulls as Dip Attracts Buyers
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
Intuitive Machines Wins NASA: Investing Outlook Ahead
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Ripple’s XRP On-Demand Liquidity: Global Payments Update
Ripple’s On-Demand Liquidity uses XRP to settle cross-border payments in seconds, cutting pre-funding needs and boost...
Live: Will Credo Keep Rallying After Q4 Earnings
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
Live: Will C3.AI Beat Q4 Earnings After Hours?
C3.AI topped Q4 expectations and provided FY27 guidance, sending shares higher after hours as investors weigh the com...
Fidelity’s Emerging Markets Stealthily Rallying Quietly Up
Fidelity’s Emerging Markets ETF has surged about 30% year-to-date, driven by chipmakers and Chinese tech names, yet r...
Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status